PatrickGArndtMD
Pulmonology • Minneapolis, MNCritical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Minnesota Medical School
Are you Dr. Arndt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
516 Delaware St Se
2nd Floor Pwb, Clinic 2a
Minneapolis, MN 55455Phone+1 612-626-6100
Summary
- Dr. Patrick Arndt, MD is a pulmonologist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota, Iowa, and Colorado. He is affiliated with M Health Fairview University of Minnesota Medical Center and M Health Fairview Southdale Hospital.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999- University of ColoradoResidency, Internal Medicine, 1992 - 1996
University of Kentucky College of MedicineClass of 1992
Certifications & Licensure
MN State Medical License 2006 - 2025
IA State Medical License 2015 - 2023
CO State Medical License 1994 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 98 citationsSelective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase.Jerry A. Nick, Scott K. Young, Patrick G. Arndt, Jonathan G. Lieber, Benjamin T. Suratt
Journal of Immunology. 2002-11-01 - 38 citationsSystemic Inhibition of the Angiotensin-Converting Enzyme Limits Lipopolysaccharide-Induced Lung Neutrophil Recruitment through Both Bradykinin and Angiotensin II-Regul...Patrick G. Arndt, Scott K. Young, Katie R. Poch, Jerry A. Nick, Sandor Falk
Journal of Immunology. 2006-11-15 - 123 citationsLipopolysaccharide-induced c-jun NH2-terminal kinase activation in human neutrophils: Role of phosphatidylinositol 3-kinase and Syk-mediated pathwaysPatrick G. Arndt, Naohito Suzuki, Natalie J. Avdi, Kenneth C. Malcolm, G. Scott Worthen
The Journal of Biological Chemistry. 2004-03-19
Grant Support
- The Role Of Syndecan-4 In The Regulation Of JNK Activation In Human NeutrophilsNational Heart, Lung, And Blood Institute2007–2011
- The LPS Responsiveness Of TLR2 An TLR4 In The NeutrophilNational Heart, Lung, And Blood Institute2002–2005
- LPS Responsiveness Of TLR2 And TLR4 In The NeutrophilNational Heart, Lung, And Blood Institute2001
